Results 321 to 330 of about 104,116 (405)
Buprenorphine Is Associated With Lower Home Opioid Use and Acute Care Utilization in Sickle Cell Disease. [PDF]
Jacobs-McFarlane C +8 more
europepmc +1 more source
Main Points AAV‐BDNF improves cognitive performance after cuprizone‐induced demyelination. BDNF promotes OPC maturation and enhances remyelination in the corpus callosum. Mitochondrial integrity is preserved through reduced swelling and improved morphology.
Yousra El Ouaamari +14 more
wiley +1 more source
Fatalities in opioid agonist treatment with long-acting injectable buprenorphine. [PDF]
Häkkinen M +3 more
europepmc +1 more source
ABSTRACT Osteochondrosis/osteochondritis dissecans (OC/OCD) is a developmental orthopedic disease primarily affecting the knee, ankle, and elbow joints of children and multiple animal species. Subclinical lesions of OC/OCD have been described, but most can be visualized only histologically in cadaveric specimens.
Alexandra R. Armstrong +3 more
wiley +1 more source
Proposed model of the interaction of the H3K18la lactylation with GATA4 to promote the cardiac hypertrophy. The image was created using Home for Researchers.com. ABSTRACT Histone lactylation, particularly histone H3 lysine 18 lactylation (H3K18la), modulates gene expression profile in diverse cellular processes, which has emerged as a critical factor ...
Mingzhu Wang +8 more
wiley +1 more source
Comparative effectiveness of alternative initial doses of opioid agonist treatment for individuals with opioid use disorder: a protocol for a retrospective population-based study using target trial emulation in British Columbia, Canada. [PDF]
Yan R +13 more
europepmc +1 more source
This study develops a novel triple‐layer chitosan film for sustained enrofloxacin delivery in rabbits. The implant significantly extends drug residence time (29‐fold) and maintains therapeutic levels for 144 h, offering a promising strategy to reduce dosing frequency in veterinary practice.
Sakineh Khanamani Falahatipour +3 more
wiley +1 more source
Motivation and experiences of individuals with opioid use disorder and chronic pain using medical cannabis for 12 months. [PDF]
Lent MR +5 more
europepmc +1 more source
Lowering the Threshold. Models of Accessible Methadone and Buprenorphine Treatment [PDF]
Keeney, Elizabeth, Saucier, Roxanne
core

